137 related articles for article (PubMed ID: 35844782)
1. miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418 : Retraction.
Wang L; Sun L; Wang Y; Yao B; Liu R; Chen T; Tu K; Liu Q; Liu Z
Int J Biol Sci; 2022; 18(10):3942. PubMed ID: 35844782
[TBL] [Abstract][Full Text] [Related]
2. miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418.
Wang L; Sun L; Wang Y; Yao B; Liu R; Chen T; Tu K; Liu Q; Liu Z
Int J Biol Sci; 2019; 15(7):1514-1522. PubMed ID: 31337980
[TBL] [Abstract][Full Text] [Related]
3. LncRNA IGFBP4-1 promotes tumor development by activating Janus kinase-signal transducer and activator of transcription pathway in bladder urothelial carcinoma: retraction.
Li C; Cao Y; Zhang L; Li J; Wu H; Ling F; Zheng J; Wang J; Li B; He J; Xie X; Li Z; Chen Y; He X; Guo M; Wei H; Ye J; Guo Y; Zhang S; Liu L; Liu G; Liu C
Int J Biol Sci; 2023; 19(15):4833. PubMed ID: 37781507
[TBL] [Abstract][Full Text] [Related]
4. LncRNA ASB16-AS1 Promotes Growth and Invasion of Hepatocellular Carcinoma Through Regulating miR-1827/FZD4 Axis and Activating Wnt/β-Catenin Pathway [Retraction].
Cancer Manag Res; 2022; 14():501-502. PubMed ID: 35177934
[TBL] [Abstract][Full Text] [Related]
5. SCAMP3 is regulated by miR-128-3p and promotes the metastasis of hepatocellular carcinoma cells through EGFR-MAPK p38 signaling pathway [Retraction].
Am J Transl Res; 2021; 13(12):14240. PubMed ID: 35035772
[TBL] [Abstract][Full Text] [Related]
6. Exosomal miR-638 Inhibits Hepatocellular Carcinoma Progression by Targeting SP1 [Retraction].
Onco Targets Ther; 2021; 14():123. PubMed ID: 33447053
[TBL] [Abstract][Full Text] [Related]
7. RETRACTION: Revealing the Effects of the Herbal Pair of Euphorbia kansui and Glycyrrhiza on Hepatocellular Carcinoma Ascites with Integrating Network Target Analysis and Experimental Validation.
Zhang Y; Lin Y; Zhao H; Guo Q; Yan C; Lin N
Int J Biol Sci; 2018; 14(11):1503. PubMed ID: 30263002
[TBL] [Abstract][Full Text] [Related]
8. Retraction Note to: Circular RNA ABCB10 promotes hepatocellular carcinoma progression by increasing HMG20A expression by sponging miR-670-3p.
Fu Y; Cai L; Lei X; Wang D
Cancer Cell Int; 2020; 20():485. PubMed ID: 33041666
[TBL] [Abstract][Full Text] [Related]
9. Retraction: Kannan et al. AEG-1/miR-221 Axis Cooperatively Regulates the Progression of Hepatocellular Carcinoma by Targeting PTEN/PI3K/AKT Signaling Pathway.
International Journal Of Molecular Sciences Editorial Office
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35708348
[TBL] [Abstract][Full Text] [Related]
10. Retraction: MiR-182-5p and miR-96-5p increased hepatocellular carcinoma cell mobility, proliferation and cisplatin resistance partially by targeting RND3.
Fisher L
RSC Adv; 2021 Jan; 11(7):4166. PubMed ID: 35427002
[TBL] [Abstract][Full Text] [Related]
11. LINC02476 Promotes the Malignant Phenotype of Hepatocellular Carcinoma by Sponging miR-497 and Increasing HMGA2 Expression [Retraction].
Onco Targets Ther; 2022; 15():145-146. PubMed ID: 35173447
[TBL] [Abstract][Full Text] [Related]
12. Retraction Notice to: circRASSF2 Acts as ceRNA and Promotes Papillary Thyroid Carcinoma Progression through miR-1178/TLR4 Signaling Pathway.
Wu G; Zhou W; Lin X; Sun Y; Li J; Xu H; Shi P; Gao L; Tian X
Mol Ther Nucleic Acids; 2021 Dec; 26():1199. PubMed ID: 34853718
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of miR-148a-3p resists hepatocellular carcinoma progress of hepatitis C virus infection through suppressing c-Jun and MAPK pathway.
Deng Y; Wang J; Huang M; Xu G; Wei W; Qin H
J Cell Mol Med; 2019 Feb; 23(2):1415-1426. PubMed ID: 30565389
[TBL] [Abstract][Full Text] [Related]
14. LncRNA NEAT1 Promotes Proliferation, Migration and Invasion via Regulating miR-296-5p/CNN2 Axis in Hepatocellular Carcinoma Cells [Retraction].
Onco Targets Ther; 2021; 14():5095-5096. PubMed ID: 34707367
[TBL] [Abstract][Full Text] [Related]
15. MiR-144 Suppresses Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma by Targeting
Onco Targets Ther; 2021; 14():3295-3296. PubMed ID: 34040393
[TBL] [Abstract][Full Text] [Related]
16. MiR-502-3P Suppresses Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma by Targeting
Onco Targets Ther; 2021; 14():3177. PubMed ID: 34040385
[TBL] [Abstract][Full Text] [Related]
17. Retraction Notice to: Exosome miR-155 Derived from Gastric Carcinoma Promotes Angiogenesis by Targeting the c-MYB/VEGF Axis of Endothelial Cells.
Deng T; Zhang H; Yang H; Wang H; Bai M; Sun W; Wang X; Si Y; Ning T; Zhang L; Li H; Ge S; Liu R; Lin D; Li S; Ying G; Ba Y
Mol Ther Nucleic Acids; 2022 Jun; 28():16. PubMed ID: 35317200
[TBL] [Abstract][Full Text] [Related]
18. MiR-21-mediated Metabolic Alteration of Cancer-associated Fibroblasts and Its Effect on Pancreatic Cancer Cell Behavior: Retraction.
Chen S; Chen X; Shan T; Ma J; Lin W; Li W; Kang Y
Int J Biol Sci; 2024; 20(4):1528. PubMed ID: 38385076
[TBL] [Abstract][Full Text] [Related]
19. Circ_LDLR Knockdown Suppresses Progression of Hepatocellular Carcinoma via Modulating miR-7/RNF38 Axis [Retraction].
Cancer Manag Res; 2022; 14():1757-1758. PubMed ID: 35637942
[TBL] [Abstract][Full Text] [Related]
20. MiR-935 Promotes Clear Cell Renal Cell Carcinoma Migration and Invasion by Targeting IREB2 [Retraction].
Cancer Manag Res; 2020; 12():7319. PubMed ID: 32904177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
